REVIVA PHARMACEUTICALS INC
RVPHLatest QuantConomy context for RVPH: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
REVIVA PHARMACEUTICALS INC
QuantConomy has a structured record for RVPH. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- RVPH
- Name
- REVIVA PHARMACEUTICALS INC
- Coverage
- 3 market/data records
- Sources
- alpaca alphavantage fmp sec nasdaq
Recent signals for RVPH
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| operating income change | very bullish | 76 | May 13, 12:00 AM | RVPH (Q1 2026, operating income): grew 83.8% (-$20.20M → -$3.27M). [sequential period basis, very bullish signal] |
| net income change | very bullish | 76 | May 13, 12:00 AM | RVPH (Q1 2026, net income): grew 83.9% (-$19.86M → -$3.20M). [sequential period basis, very bullish signal] |
| earnings release | neutral | 40 | May 13, 12:00 AM | RVPH filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-05-13. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
FUNDAMENTAL signals are experimental: the generator was recently enabled and coverage is still being validated.
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| RVPH | NASDAQ | alpaca | Reviva Pharmaceuticals Holdings, Inc. Common Stock |
| RVPH | NASDAQ | alphavantage | Reviva Pharmaceuticals Holdings Inc |
| RVPH | NASDAQ | fmp | Reviva Pharmaceuticals Holdings, Inc. |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Prabhu Narayan | Chief Financial Officer | grant | 40,925 | — | — | 4 on EDGAR |
| Mar 18, 2026 | Bhat Laxminarayan | President and CEO | grant | 109,150 | — | — | 4 on EDGAR |
| Dec 18, 2025 | Margolin Richard A | Insider | grant | 8,200 | — | — | 4 on EDGAR |
| Dec 18, 2025 | Funtleyder Leslie D. | Insider | grant | 8,200 | — | — | 4 on EDGAR |
| Dec 18, 2025 | SAXENA PARAG | Insider | grant | 8,200 | — | — | 4 on EDGAR |
| Dec 18, 2025 | Patel Purav | Insider | grant | 8,200 | — | — | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query RVPH context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access